These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36801845)

  • 1. Primary Care Implications of the Expanded National Guidelines for Germline Testing of Patients Previously Diagnosed with Colorectal Cancer.
    Sorscher S
    J Am Board Fam Med; 2023 Apr; 36(2):360-365. PubMed ID: 36801845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
    Jiang W; Li L; Ke CF; Wang W; Xiao BY; Kong LH; Tang JH; Li Y; Wu XD; Hu Y; Guo WH; Wang SZ; Wan DS; Xu RH; Pan ZZ; Ding PR
    J Med Genet; 2022 Apr; 59(4):370-376. PubMed ID: 33563768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiencies in germline genetic testing in young-onset colorectal cancer patients.
    Ficarino H; Cage B; Osula JP; Heatherly A; Chu D; Reddy S; Bhatia S; Hollis R
    Am J Surg; 2024 Jun; 232():126-130. PubMed ID: 38302366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
    Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Mao R; Krautscheid P; Graham RP; Ganguly A; Shankar S; Ferber M; Hegde M;
    Genet Med; 2021 Oct; 23(10):1807-1817. PubMed ID: 34140662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
    Uson PLS; Riegert-Johnson D; Boardman L; Kisiel J; Mountjoy L; Patel N; Lizaola-Mayo B; Borad MJ; Ahn D; Sonbol MB; Jones J; Leighton JA; Gurudu S; Singh H; Klint M; Kunze KL; Golafshar MA; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab TS; Jewel Samadder N
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e508-e528. PubMed ID: 33857637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.
    Boardman LA; Vilar E; You YN; Samadder J
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2415-2424. PubMed ID: 32525015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.
    Coughlin SE; Heald B; Clark DF; Nielsen SM; Hatchell KE; Esplin ED; Katona BW
    JCO Precis Oncol; 2022 Nov; 6():e2200517. PubMed ID: 36370464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
    Vasen HF; Möslein G; Alonso A; Aretz S; Bernstein I; Bertario L; Blanco I; Bulow S; Burn J; Capella G; Colas C; Engel C; Frayling I; Rahner N; Hes FJ; Hodgson S; Mecklin JP; Møller P; Myrhøj T; Nagengast FM; Parc Y; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen J; Lubinski J; Järvinen H; Claes E; Heinimann K; Karagiannis JA; Lindblom A; Dove-Edwin I; Müller H
    Fam Cancer; 2010 Jun; 9(2):109-15. PubMed ID: 19763885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.
    Djursby M; Hansen TVO; Wadt KAW; Madsen MB; Berchtold LA; Lautrup CK; Markholt S; Jensen UB; Krogh LN; Lundsgaard M; Gerdes AM; Nilbert M; Therkildsen C
    Hum Genet; 2022 Dec; 141(12):1925-1933. PubMed ID: 35904628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
    Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
    Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
    Provenzale D; Gupta S; Ahnen DJ; Bray T; Cannon JA; Cooper G; David DS; Early DS; Erwin D; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Hampel H; Ismail MK; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Mayer RJ; Ness RM; Regenbogen SE; Samadder NJ; Shike M; Steinbach G; Weinberg D; Dwyer M; Darlow S
    J Natl Compr Canc Netw; 2016 Aug; 14(8):1010-30. PubMed ID: 27496117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of genetic testing for colorectal cancer susceptibility.
    Solomon CH; Pho LN; Burt RW
    Oncology (Williston Park); 2002 Feb; 16(2):161-71; discussion 176, 179-80. PubMed ID: 11866134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Germline Mutations in Polyposis and Colorectal Cancer-Associated Genes in Patients With Multiple Colorectal Polyps.
    Stanich PP; Pearlman R; Hinton A; Gutierrez S; LaDuca H; Hampel H; Jasperson K
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2008-2015.e3. PubMed ID: 30557735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
    Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD
    Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.